Phase IIb multicentre, randomised, open-label, parallel study to compare the efficacy and safety of metoclopramide nasal spray to oral tablets in patients with diabetic gastroparesis

Trial Profile

Phase IIb multicentre, randomised, open-label, parallel study to compare the efficacy and safety of metoclopramide nasal spray to oral tablets in patients with diabetic gastroparesis

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs Metoclopramide (Primary) ; Metoclopramide (Primary)
  • Indications Diabetic gastroparesis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Mar 2014 Results will be presented at the 26th Annual ROTH Conference according to an Evoke Pharma media release.
    • 07 Feb 2014 New trial record
    • 22 Jan 2014 Results were published online ahead-of-print in Neurogastroenterology & Motility, according to an Evoke Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top